Welcome to the real world Matthew Gordon examines the differences between observational studies and phase III clinical trials(more)
Drug regulation: still room for improvement The Medicines Act is 40 years old this year, but regulations and regulators have to change to keep up with rapid changes in medicines and society, says Les Rose.(more)
Top Pharmaceutical Employers Wednesday, June 14, 2006
A guide to the leading employers in the UK pharmaceutical industry
Published October 2005...(more)
Brands:looking at the bigger picture Thursday , June 01, 2006
Viewing products as separate entities means missing opportunities. Good portfolio management demands an interdependent approach - but this requires a new thinking, argues Gerard Doherty...(more)
Herceptin and the rise of patient power Thursday , June 01, 2006
The story of the fight over Herceptin in the UK has been a truly exceptional one so far, but could be a true landmark for NHS rationing and patient power, argues David Lewis...(more)
Is pharma fit for the future? Thursday , June 01, 2006
The pharma industry must ensure it plays a major role in delivering better health outcomes and easing the healthcare funding burden in the future, says Guenther Illert...(more)
